This presentation highlights the key recommendations of the AASLD 2025 guidelines. Topics discussed include the role of perfusion technologies in liver transplantation, optimal immunosuppression strategies across a spectrum of conditions, and the evaluation and treatment of biliary tract complications in the allograft. It discusses the 2025 guidance for immunosuppression monitoring and how to recognize and manage different forms of allograft injury. The key recommendations for the use of hepatitis C and hepatitis B infected organs are reviewed along with the management of patients transplanted for alcohol associated liver disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Top 6 courses
-

-

-

-

-

-
Guideline Update: PSVD-NCPF Nomenclature0.5 Credits
Specialties served/covered
- Adolescent Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Interventional Radiology
- Medical Oncology
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Transplant Hepatology
- Radiation Oncology
- Surgical Oncology
- Transplant Hepatology
- Cross-Specialty
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- No reviews yet. Be the first to share yours.


